Photo of Bob Gibbs
R United States House · District 7 · Ohio

Rep. Bob Gibbs

Compare
Total votes
958
all sessions
Attendance
95%
50 missed
Lower than 91% of chamber peers
With party
96%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
334
bills & resolutions
Near the chamber average
Committees
0
assignments
334 bills and resolutions

Sponsored bills

Total
334
Primary
16
Co-sponsor
318
This page
334
matching current filters
Co-sponsor HR 5847
In committee · United States House · Co-sponsor
SANTA 18 Act

Supplying America Needs Truckers Aged 18 Act or the SANTA 18 Act This bill exempts drivers who transport goods from a port of entry and another place within the same state from age restrictions and other requirements that apply to federal commercial driver's licenses.

In committee Nov 3, 2021 1 co-sponsor
Co-sponsor HRES 754
In committee · United States House · Co-sponsor
Expressing that the House of Representatives opposes punitive natural gas taxes on United States businesses, families, and workers.

Maddy summaryHRES 754 is a non-binding resolution expressing the House of Representatives' opposition to proposed "punitive natural gas taxes" on U.S. businesses, families, and workers. It cites claims that such taxes would raise average energy bills by 17%, reduce GDP by $9 billion, and eliminate 90,000 jobs, while disproportionately harming low-income households. The resolution argues that opposing these taxes supports U.S. energy security, national security, and continued leadership in reducing emissions through domestic natural gas production. As a procedural resolution, it does not create law but formally states the House's position against this policy approach.

In committee Nov 2, 2021 1 co-sponsor
Co-sponsor HR 3860
In committee · United States House · Co-sponsor
To prohibit any requirement that a member of the Armed Forces receive a vaccination against COVID-19.

This bill prohibits the use of federal funds to require a member of the Armed Forces to receive a COVID-19 vaccination. The bill also prohibits adverse action (e.g., punishment) being taken against a member of the Armed Forces because the member refuses to receive a COVID-19 vaccination.

In committee Nov 1, 2021 1 co-sponsor
Co-sponsor HR 5777
In committee · United States House · Co-sponsor
CHOICE Act

Connecting Higher Opportunities In College Education Act or the CHOICE Act This bill makes certain job training programs eligible for federal student aid. To be eligible, a program must (1) provide at least 150 clock hours, 4 semester hours, or 6 quarter hours of instructional time over a minimum of 8 weeks; (2) have verified completion and placement rates meeting a minimum standard; and (3) provide training aligned with high-skill, high-wage, or in-demand industry sectors or occupations in the state or local area in which the program is provided.

In committee Oct 28, 2021 1 co-sponsor
Co-sponsor HR 5731
In committee · United States House · Co-sponsor
Championing our Parents Act of 2021

Championing our Parents Act of 2021 This bill prohibits the use of federal funds to facilitate certain law enforcement partnerships to address threats against school personnel.

In committee Oct 26, 2021 1 co-sponsor
Co-sponsor HRES 352
In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2779
In committee · United States House · Co-sponsor
ALERT Act of 2021

All Economic Regulations are Transparent Act of 2021 or the ALERT Act of 2021 This bill establishes various reporting requirements with respect to federal agency rulemaking. Specifically, each agency must submit a monthly report to the Office of Information and Regulatory Affairs (OIRA) for each rule the agency expects to propose or finalize during the following year, including information about the objectives and legal basis for the rule as well as whether the rule is subject to periodic review based on its significant economic impact. Additionally, each agency must submit a monthly report for any rule expected to be finalized during the following year for which the agency has issued a general notice of proposed rulemaking, including an approximate schedule for completing action on the rule and an estimate of its cost and economic effects. OIRA must publish this information online and, subject to certain exceptions, a rule may not take effect until the information has been published for at least six months. The bill also requires OIRA to annually publish in the Federal Register specified information it receives from agencies under this bill, including a list of each rule an agency has proposed and the total cost of all rules proposed or finalized. OIRA must further publish online (1) any analysis of the costs or benefits of rules that were proposed or finalized during the previous year, and (2) a list of rules that were subjected to various forms of review during the previous year.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 19
In committee · United States House · Co-sponsor
Lower Costs, More Cures Act of 2021

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2718
In committee · United States House · Co-sponsor
Maximum Pressure Act

Maximum Pressure Act This bill expands sanctions and economic penalties on Iran. It also restricts the President from unilaterally lifting or waiving the sanctions or penalties and increases congressional oversight of them. Specifically, the bill requires the President to impose visa- and asset-blocking sanctions. Additionally, it modifies existing sanctions, including by (1) providing statutory authority for executive orders imposing sanctions; (2) applying sanctions to additional sectors of Iran's economy; and (3) broadening sanctionable conduct to cover, for example, assisting Iran with the acquisition of ballistic missiles and the complicity of Iranian officials in human rights violations in specified countries. The bill also requires reporting on licenses that authorize activities subject to sanctions. The bill prohibits U.S. representatives at the International Monetary Fund from voting to allow Iran's access to special drawing rights (a currency support tool) and places restrictions on financial transactions with Iran. The restrictions include requiring domestic financial institutions to implement special measures with respect to foreign financial institutions that conduct significant transactions connected to the Instrument in Support of Trade Exchanges (a European mechanism that bypasses U.S. sanctions when carrying out trade with Iran). The Department of State must maintain the Islamic Revolutionary Guard Corps' designation as a terrorist organization and must designate Ansharallah (or Houthis), which operates in Syria, as a foreign terrorist organization. The bill also requires reports on U.S. sanctions concerning Iran, the status of Iran's nuclear weapons program, and other matters.

In committee Oct 19, 2021 1 co-sponsor
Showing 171 to 180 of 334 bills
Previous 1 … 17 18 19 … 34 Next